Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.52 |
| ▸ | TSHR | P16473 | 6/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.52 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.42 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.37 |
| ▸ | CHKA | P35790 | 1/20 | 0.37 |
| ▸ | HBB | P68871 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29789670 | 0.98 | ALDH1A1 (0.50) | ALDH1A1TSHRALOX15HSD17B10SLC2A1 | |
| SCHEMBL9939143 | 0.98 | ALDH1A1 (0.50) | ALDH1A1TSHRALOX15HSD17B10SLC2A1 | |
| Hydrochloric Acid SCHEMBL27243769 | 0.98 | ALDH1A1 (0.50) | ALDH1A1TSHRALOX15HSD17B10SLC2A1 | |
| SCHEMBL29482181 | 0.98 | ALDH1A1 (0.50) | ALDH1A1TSHRALOX15HSD17B10SLC2A1 | |
| Hydrochloric Acid SCHEMBL30670337 | 0.98 | ALDH1A1 (0.50) | ALDH1A1TSHRALOX15HSD17B10SLC2A1 | |
| Hydrochloric Acid SCHEMBL28840014 | 0.98 | ALDH1A1 (0.50) | ALDH1A1TSHRALOX15HSD17B10SLC2A1 | |
| Hydrochloric Acid SCHEMBL28153388 | 0.98 | ALDH1A1 (0.50) | ALDH1A1TSHRALOX15HSD17B10SLC2A1 | |
| SCHEMBL27822750 | 0.98 | ALDH1A1 (0.50) | ALDH1A1TSHRALOX15HSD17B10SLC2A1 | |
| Hydrochloric Acid SCHEMBL28596190 | 0.96 | ALDH1A1 (0.48) | ALDH1A1TSHRALOX15HSD17B10SLC2A1 | |
| Hydrochloric Acid SCHEMBL114430 | 0.96 | ALDH1A1 (0.48) | ALDH1A1TSHRALOX15HSD17B10SLC2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1526 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4745179-A1 | METHOD FOR PRODUCING ARYLAMINE POLYMER | Resonac Corporation (JP) | 2026-05-20 | — | — | EP | claimed |
| WO-2026090336-A1 | PROCESSES FOR PREPARING KRAS INHIBITORS | INCYTE CORPORATION (US) | 2026-04-30 | — | — | WO | claimed |
| EP-4725945-A1 | PREPARATION METHOD FOR FORMAMIDE COMPOUNDS | Shanghai Senhui Medicine Co., Ltd. (CN) | 2026-04-15 | — | — | EP | claimed |
| EP-4321501-B1 | METHOD FOR SYNTHESIZING DIMETHYL 3-(3-OXO-2-PENTYL)CYCLOPENTYLMALONATE AND CATALYST | ZHEJIANG XINHUA CHEMICAL CO LTD (CN) | 2025-10-01 | — | — | EP | claimed |
| WO-2025080589-A1 | PROCESSES FOR PREPARING KRAS INHIBITORS | INCYTE CORPORATION (US) | 2025-04-17 | — | — | WO | claimed |
| US-20250092008-A1 | PROCESS FOR MAKING AN EP4 ANTAGONIST | ONO PHARMACEUTICAL CO., LTD. (JP) | 2025-03-20 | — | — | US | claimed |
| US-12233402-B2 | Cross-coupling reaction catalysts, and methods of making and using same | YALE UNIVERSITY (US) | 2025-02-25 | — | — | US | claimed |
| EP-4493533-A1 | BIOCATALYTIC SYNTHESIS OF (1S,3S)-3-HYDROXYCYCLOHEXANE-1-CARBOXYLIC ACID COMPOUNDS | Bristol-Myers Squibb Company (US) | 2025-01-22 | — | — | EP | claimed |
| WO-2025013810-A1 | METHOD FOR PRODUCING ARYLAMINE POLYMER | 株式会社レゾナック | 2025-01-16 | — | — | WO | claimed |
| CN-119241533-A | Preparation method of tetrahydro-gamma-carboline | 湖北科技学院 | 2025-01-03 | — | — | CN | claimed |
| CN-105237568-B | The preparation method of the dimethylamino phenyl phosphine of di-t-butyl 4 and double (the dimethylamino phenyl phosphine of di-t-butyl 4) palladium bichlorides | 盘锦格林凯默科技有限公司 | 2017-06-20 | — | — | CN | claimed |
| US-20160280635-A1 | IMPROVED PROCESS FOR PREPARING CHLORINATED BIPHENYLANILIDES AND BIPHENYLANILINES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-09-29 | — | — | US | claimed |
| WO-2016057600-A1 | NOVEL PRECATALYST SCAFFOLDS FOR CROSS-COUPLING REACTIONS, AND METHODS OF MAKING AND USING SAME | YALE UNIVERSITY (US) | 2016-04-14 | — | — | WO | claimed |
| CN-105481639-A | Method for preparing biphenyl compound | FUYANG XINYIHUA MAT TECH CO LTD | 2016-04-13 | — | — | CN | claimed |
| CN-105237568-A | Preparing method for di-tertiary butyl-4-dimethylamino phenylphosphine and bis(di-tertiary butyl-4-dimethylamino phenylphosphine) palladium chloride | PANJIN GELIN KAIMO TECHNOLOGY CO LTD | 2016-01-13 | — | — | CN | claimed |
| US-9233922-B2 | Process for producing N-(hetero)arylazoles | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-01-12 | — | — | US | claimed |
| US-9068045-B2 | Curing of liquid thermosetting resins | REICHHOLD, INC. (US) | 2015-06-30 | — | — | US | claimed |
| US-20140303315-A1 | CURING OF LIQUID THERMOSETTING RESINS | Polynt Composites USA Inc. | 2014-10-09 | — | — | US | claimed |
| WO-2012159981-A2 | PROCESS FOR THE PREPARATION OF α-SUBSTITUTED KETONES AND THEIR APPLICATION IN SYNTHESIS OF PHARMACEUTICALLY ACTIVE COMPOUNDS | LEK PHARMACEUTICALS D.D. (SI) | 2012-11-29 | — | — | WO | claimed |
| EP-2524908-A1 | Process for the preparation of alfa-substituted ketones and their application in synthesis of pharmaceutically active compounds | LEK Pharmaceuticals d.d. (SI) | 2012-11-21 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160280635-A1 | IMPROVED PROCESS FOR PREPARING CHLORINATED BIPHENYLANILIDES AND BIPHENYLANILINES | CYP2F1, CYP1A1, CYP4F12 | ALDH1A1 798/4885TSHR 661/4885ALOX15 3842/4885 |
| US-20250092008-A1 | PROCESS FOR MAKING AN EP4 ANTAGONIST | PTGER4, LTB4R2, EPB41 | ALDH1A1 1405/4885TSHR 1750/4885ALOX15 34/4885 |
| US-12233402-B2 | Cross-coupling reaction catalysts, and methods of making and using same | TET2, TIMCC, MDM4 | ALDH1A1 1625/4885TSHR 4878/4885ALOX15 1242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.